PFOS significantly increased the numbers of LC3 puncta in a time-dependent fashion
A brief history and critical analysis of recent reports
Son principal compos, la silymarine, aide les cellules hpatiques se protger des toxines et mieux se rgnrer
Leaders in the field stressed that conducting large, rigorous studies, even the long-shot ones, helps close unproductive avenues, clarify hypotheses, and guide investment toward more promising strategies
Because youre not as far as you think
79 However, the FDA revised its guidance in 2020, moving toward a risk-based approach in which the need for a cardiovascular outcome trial is determined based on the drugs characteristics, safety profile, and existing cardiovascular risk data